Brian Lian sold $1.4M of Viking Therapeutics (VKTX)

Executed Oct 28 2025, disclosed Oct 28 2025, the same day.

Value, as filed

$1.4M

38,989 sh × $35.01

Executed

Oct 28 2025

the trade date, as filed

Disclosed

Oct 28 2025

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Brian Lian President & CEO profile →

Brian Lian (President & CEO) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Viking Therapeutics, Inc. (VKTX). The largest single filing was $7.7M of VKTX (233,409 sh across 4 lots, as filed), executed Jan 5.

The name

VKTX

Viking Therapeutics, Inc. VKTX · Healthcare · 22 filings in 24 months ticker →

Healthcare · Viking Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development of novel therapies for metabolic and endo…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Brian Lian in VKTX

VKTXSALE Viking Therapeutics, Inc. $4.9M
148,517 sh × $33.32
Exec Jul 29
Filed Jul 29 · 8:07 PM ET VKTXSALE Viking Therapeutics, Inc. $7.7M
233,409 sh across 4 lots
Exec Jan 5
Filed Jan 5 · 5:30 PM ET VKTXSALE Viking Therapeutics, Inc. $748K
26,889 sh × $27.80
Exec Jul 3 2025
Filed Jul 3 2025 · 5:30 PM ET VKTXSALE Viking Therapeutics, Inc. $8.3M
194,490 sh across 2 lots
Exec Jan 6 2025
Filed Jan 6 2025 · 5:30 PM ET VKTXSALE Viking Therapeutics, Inc. $15.3M
215,930 sh across 2 lots
Exec Sep 20 2024
Filed Sep 20 2024 · 5:30 PM ET